Frank Ruschitzka

Summary

Affiliation: University Hospital
Country: Switzerland

Publications

  1. doi request reprint Prophylactic implantable cardioverter defibrillator treatment in patients with end-stage heart failure awaiting heart transplantation
    Georg M Fröhlich
    Cardiovascular Division, University Hospital Zurich, Raemistrasse 100, Zurich CH 8091, Switzerland
    Heart 99:1158-65. 2013
  2. doi request reprint Evidence for improvement in survival with antihypertensive combination treatment
    Frank Ruschitzka
    Heart Failure Transplantation Clinic, University Clinic Zurich, Switzerland
    J Hypertens 29:S9-14. 2011
  3. doi request reprint Cardiovascular effects of flavanol-rich chocolate in patients with heart failure
    Andreas J Flammer
    Cardiovascular Center, Cardiology University Hospital Zurich, Raemistrasse 100, Zurich, Switzerland
    Eur Heart J 33:2172-80. 2012
  4. doi request reprint Effects of Pycnogenol on endothelial function in patients with stable coronary artery disease: a double-blind, randomized, placebo-controlled, cross-over study
    Frank Enseleit
    Cardiovascular Center Cardiology, University Hospital Zurich, Ramistrasse 100, Zurich, Switzerland
    Eur Heart J 33:1589-97. 2012
  5. ncbi request reprint Effect of losartan, compared with atenolol, on endothelial function and oxidative stress in patients with type 2 diabetes and hypertension
    Andreas J Flammer
    Cardiovascular Center, Cardiology, University Hospital Zurich, Switzerland
    J Hypertens 25:785-91. 2007
  6. doi request reprint Cocoa, blood pressure, and vascular function
    Isabella Sudano
    Cardiovascular Center Cardiology, University Hospital Zurich, Raemistrasse 100, CH 8091, Zurich, Switzerland
    Curr Hypertens Rep 14:279-84. 2012
  7. doi request reprint Cholesterylestertransfer protein inhibition and endothelial function in type II hyperlipidemia
    Frank Hermann
    University Hospital Zurich, Zurich, Switzerland
    Thromb Res 123:460-5. 2009
  8. ncbi request reprint Dark chocolate improves coronary vasomotion and reduces platelet reactivity
    Andreas J Flammer
    Cardiovascular Center, Cardiology, University Hospital Zurich, Raemistr 100, CH 8091 Zurich, Switzerland
    Circulation 116:2376-82. 2007
  9. doi request reprint Nonsteroidal antiinflammatory drugs, acetaminophen, and hypertension
    Isabella Sudano
    Cardiovascular Center Cardiology, University Hospital Zurich, Ramistrasse 100, 8091, Zurich, Switzerland
    Curr Hypertens Rep 14:304-9. 2012
  10. ncbi request reprint Coffee blunts mental stress-induced blood pressure increase in habitual but not in nonhabitual coffee drinkers
    Isabella Sudano
    Cardiovascular Center, Cardiology, University Hospital Zurich, Zurich, Switzerland
    Hypertension 46:521-6. 2005

Collaborators

Detail Information

Publications22

  1. doi request reprint Prophylactic implantable cardioverter defibrillator treatment in patients with end-stage heart failure awaiting heart transplantation
    Georg M Fröhlich
    Cardiovascular Division, University Hospital Zurich, Raemistrasse 100, Zurich CH 8091, Switzerland
    Heart 99:1158-65. 2013
    ..This study was designed to delineate the role of implantable cardioverter defibrillator (ICD) therapy for the primary and secondary prevention of sudden cardiac death in patients listed for heart transplantation...
  2. doi request reprint Evidence for improvement in survival with antihypertensive combination treatment
    Frank Ruschitzka
    Heart Failure Transplantation Clinic, University Clinic Zurich, Switzerland
    J Hypertens 29:S9-14. 2011
    ..The best clinical trial evidence comes from large outcome studies with an ACE inhibitor and dihydropyridine calcium antagonist combination, that of perindopril/amlodipine in the ASCOT trial in particular...
  3. doi request reprint Cardiovascular effects of flavanol-rich chocolate in patients with heart failure
    Andreas J Flammer
    Cardiovascular Center, Cardiology University Hospital Zurich, Raemistrasse 100, Zurich, Switzerland
    Eur Heart J 33:2172-80. 2012
    ..As statins are ineffective in CHF, alternative therapies are a clinical need. We therefore investigated whether FRC might improve cardiovascular function in patients with CHF...
  4. doi request reprint Effects of Pycnogenol on endothelial function in patients with stable coronary artery disease: a double-blind, randomized, placebo-controlled, cross-over study
    Frank Enseleit
    Cardiovascular Center Cardiology, University Hospital Zurich, Ramistrasse 100, Zurich, Switzerland
    Eur Heart J 33:1589-97. 2012
    ..atlantica) that exerts antioxidative, anti-inflammatory, and anti-platelet effects. However, the effects of Pycnogenol on endothelial dysfunction, a precursor of atherosclerosis and cardiovascular events, remain still elusive...
  5. ncbi request reprint Effect of losartan, compared with atenolol, on endothelial function and oxidative stress in patients with type 2 diabetes and hypertension
    Andreas J Flammer
    Cardiovascular Center, Cardiology, University Hospital Zurich, Switzerland
    J Hypertens 25:785-91. 2007
    ..We investigated the influence of losartan, compared with atenolol, on endothelial function and oxidative stress in patients with type 2 diabetes and hypertension...
  6. doi request reprint Cocoa, blood pressure, and vascular function
    Isabella Sudano
    Cardiovascular Center Cardiology, University Hospital Zurich, Raemistrasse 100, CH 8091, Zurich, Switzerland
    Curr Hypertens Rep 14:279-84. 2012
    ..It is the aim of this review to summarize the findings of cocoa and chocolate on blood pressure and vascular function...
  7. doi request reprint Cholesterylestertransfer protein inhibition and endothelial function in type II hyperlipidemia
    Frank Hermann
    University Hospital Zurich, Zurich, Switzerland
    Thromb Res 123:460-5. 2009
    ....
  8. ncbi request reprint Dark chocolate improves coronary vasomotion and reduces platelet reactivity
    Andreas J Flammer
    Cardiovascular Center, Cardiology, University Hospital Zurich, Raemistr 100, CH 8091 Zurich, Switzerland
    Circulation 116:2376-82. 2007
    ..Thus, flavonoid-rich dark chocolate holds the potential to have a beneficial impact on graft atherosclerosis...
  9. doi request reprint Nonsteroidal antiinflammatory drugs, acetaminophen, and hypertension
    Isabella Sudano
    Cardiovascular Center Cardiology, University Hospital Zurich, Ramistrasse 100, 8091, Zurich, Switzerland
    Curr Hypertens Rep 14:304-9. 2012
    ..selective COX inhibitors are currently underway. This review summarizes the current knowledge on the cardiovascular effects of NSAIDs and acetaminophen, and their potential clinical consequences...
  10. ncbi request reprint Coffee blunts mental stress-induced blood pressure increase in habitual but not in nonhabitual coffee drinkers
    Isabella Sudano
    Cardiovascular Center, Cardiology, University Hospital Zurich, Zurich, Switzerland
    Hypertension 46:521-6. 2005
    ..Caffeine alone does not exert any potentiating effect, confirming that ingredients other than caffeine are partially responsible for the stimulating effect of coffee on the cardiovascular system...
  11. doi request reprint Takotsubo cardiomyopathy has a unique cardiac biomarker profile: NT-proBNP/myoglobin and NT-proBNP/troponin T ratios for the differential diagnosis of acute coronary syndromes and stress induced cardiomyopathy
    Georg M Fröhlich
    Cardiovascular Center Cardiology, University Hospital Zurich, Zurich, Switzerland
    Int J Cardiol 154:328-32. 2012
    ..It was our aim to identify TC by its unique cardiac biomarker profile at an early stage and, preferably, with non-invasive procedures only...
  12. doi request reprint Characteristics and long-term outcome of echocardiographic super-responders to cardiac resynchronisation therapy: 'real world' experience from a single tertiary care centre
    Jan Steffel
    Department of Cardiology, University Hospital Zurich, Ramistrasse 100, Zurich 8091, Switzerland
    Heart 97:1668-74. 2011
    ..The individual benefit from cardiac resynchronisation therapy (CRT) varies largely among patients...
  13. doi request reprint Haemodynamically irrelevant pericardial effusion is associated with increased mortality in patients with chronic heart failure
    Georg M Fröhlich
    Cardiovascular Center, Cardiology, University Hospital Zurich, Ramistrasse 100, Zurich CH 8091, Switzerland
    Eur Heart J 34:1414-23. 2013
    ..Pericardial effusion (PE) is a common finding in cardiac patients with chronic heart failure. The prognostic relevance of a small, haemodynamically non-compromising PE in such patients, however, remains to be determined...
  14. doi request reprint Cyclosporine C0- versus C2-monitoring over three years in maintenance heart transplantation
    Matthias Hermann
    Cardiovascular Center Cardiology, University Hospital Zurich, Ramistrasse 100, 8091 Zurich, Switzerland
    Swiss Med Wkly 141:w13149. 2011
    ..In particular, data from long-term maintenance patients are not available...
  15. doi request reprint Upgrading to resynchronization therapy after chronic right ventricular pacing improves left ventricular remodelling
    Georg Fröhlich
    Cardiovascular Center, Cardiology, University Hospital Zurich, Raemistrasse 100, Zurich CH 8091, Switzerland
    Eur Heart J 31:1477-85. 2010
    ..Upgrading patients with chronic RV pacing to cardiac resynchronization therapy (CRT) may be considered to restore synchronicity and prevent these deleterious effects...
  16. doi request reprint Statins and the risk of cancer after heart transplantation
    Georg Marcus Fröhlich
    Cardiovascular Center Cardiology, Heart Failure Transplantation Clinic, University Hospital Zurich, Ramistrasse 100, CH 8091 Zurich, Switzerland
    Circulation 126:440-7. 2012
    ..Statins may have an impact on clinical outcomes beyond their lipid-lowering effects. The aim of the present study was to delineate whether statin therapy has an impact on cancer risk and total mortality after heart transplantation...
  17. doi request reprint NT-proBNP provides incremental prognostic information in cardiac outpatients with and without echocardiographic findings
    Stefan Toggweiler
    Department of Cardiology, Cardiovascular Center, University Hospital Zurich, Zurich, Switzerland
    Clin Cardiol 34:183-8. 2011
    ..Outpatients frequently present with elevated natriuretic peptides in the absence of an obvious cardiac abnormality or with normal natriuretic peptides despite echocardiographic findings...
  18. ncbi request reprint Cardiac resynchronization therapy in patients with a narrow QRS
    Johannes Holzmeister
    Cardiovascular Center, University Hospital Zurich, Ramistrasse 100, Zurich, Switzerland
    Curr Heart Fail Rep 6:49-56. 2009
    ..Such a trial, the EchoCRT trial, has recently been launched...
  19. ncbi request reprint Cardiovascular risk of cyclooxygenase-2 inhibitors and traditional non-steroidal anti-inflammatory drugs
    Matthias Hermann
    Cardiology, Cardiovascular Center, University Hospital Zurich, Switzerland
    Ann Med 39:18-27. 2007
    ....
  20. ncbi request reprint Images in cardiovascular medicine. The blue man: amiodarone-induced skin discoloration
    Frank Enseleit
    Cardiovascular Center Cardiology, University Hospital Zurich, Zurich, Switzerland
    Circulation 113:e63. 2006
  21. ncbi request reprint Cardiovascular effects of coffee: is it a risk factor?
    Isabella Sudano
    Department of Internal Medicine, Cardiology Unit, University Hospital Zurich, Zurich, Switzerland
    Prog Cardiovasc Nurs 20:65-9. 2005
    ..In contrast to early studies, recent research indicates that habitual moderate coffee intake does not represent a health hazard and may even be associated with beneficial effects on cardiovascular health...
  22. ncbi request reprint Selective COX-2 inhibition improves endothelial function in coronary artery disease
    Remy Chenevard
    Cardiovascular Center, Cardiology and Department of Rheumatology, University Hospital Zurich, Switzerland
    Circulation 107:405-9. 2003
    ....